0:00
37:32
WOW. There has been a lot of new developments in the ObGyn world within the last 48 hours. In this episode, we will highlight 3 big developments/alerts regarding women’s healthcare: 1. the FDA’s approval of a new oral antibiotic for UTIs in females; 2. The updated ACOG practice advisory regarding maternal cell-free fetal RHD testing; and 3. The FDA’s recent (within last 24 hours) clearance of a new digital app for postpartum depression (MAMMALIFT). Special shout out to Dr. Colton for bringing MAMMALIFT to my attention.
Mais episódios de "Dr. Chapa’s Clinical Pearls."
Não percas um episódio de “Dr. Chapa’s Clinical Pearls.” e subscrevê-lo na aplicação GetPodcast.